Cambridge Investment Research Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.51M Buy
9,736
+605
+7% +$156K 0.01% 1258
2025
Q1
$2.04M Sell
9,131
-554
-6% -$124K 0.01% 1324
2024
Q4
$2.22M Buy
9,685
+531
+6% +$121K 0.01% 1295
2024
Q3
$2.24M Buy
9,154
+1,302
+17% +$318K 0.01% 1269
2024
Q2
$1.5M Buy
7,852
+871
+12% +$167K 0.01% 1487
2024
Q1
$1.38M Sell
6,981
-7,903
-53% -$1.56M 0.01% 1508
2023
Q4
$2.56M Buy
14,884
+9,442
+174% +$1.62M 0.01% 1045
2023
Q3
$805K Buy
5,442
+1,863
+52% +$276K ﹤0.01% 1714
2023
Q2
$782K Buy
3,579
+374
+12% +$81.7K ﹤0.01% 1788
2023
Q1
$702K Buy
3,205
+111
+4% +$24.3K ﹤0.01% 1826
2022
Q4
$644K Sell
3,094
-95
-3% -$19.8K ﹤0.01% 1830
2022
Q3
$696K Sell
3,189
-232
-7% -$50.6K ﹤0.01% 1718
2022
Q2
$717K Buy
3,421
+371
+12% +$77.8K ﹤0.01% 1699
2022
Q1
$740K Buy
3,050
+414
+16% +$100K ﹤0.01% 1808
2021
Q4
$687K Buy
2,636
+162
+7% +$42.2K ﹤0.01% 1854
2021
Q3
$652K Buy
2,474
+695
+39% +$183K ﹤0.01% 1840
2021
Q2
$439K Sell
1,779
-85
-5% -$21K ﹤0.01% 2155
2021
Q1
$362K Sell
1,864
-267
-13% -$51.9K ﹤0.01% 2151
2020
Q4
$453K Sell
2,131
-324
-13% -$68.9K ﹤0.01% 1835
2020
Q3
$421K Sell
2,455
-1,378
-36% -$236K ﹤0.01% 1716
2020
Q2
$736K Buy
3,833
+232
+6% +$44.5K 0.01% 1313
2020
Q1
$530K Buy
3,601
+891
+33% +$131K 0.01% 1330
2019
Q4
$420K Sell
2,710
-44
-2% -$6.82K ﹤0.01% 1690
2019
Q3
$372K Buy
2,754
+187
+7% +$25.3K ﹤0.01% 1688
2019
Q2
$313K Sell
2,567
-12,025
-82% -$1.47M ﹤0.01% 1721
2019
Q1
$1.52M Sell
14,592
-128
-0.9% -$13.3K 0.01% 833
2018
Q4
$1.68M Buy
14,720
+1,142
+8% +$130K 0.02% 700
2018
Q3
$1.57M Buy
13,578
+930
+7% +$107K 0.02% 786
2018
Q2
$1.31M Buy
+12,648
New +$1.31M 0.01% 837
2017
Q2
Sell
-2,944
Closed -$212K 1978
2017
Q1
$212K Buy
+2,944
New +$212K ﹤0.01% 1580
2015
Q2
Sell
-9,470
Closed -$680K 1485
2015
Q1
$680K Sell
9,470
-177
-2% -$12.7K 0.02% 654
2014
Q4
$541K Buy
+9,647
New +$541K 0.02% 739